ArticlePloS one2018

Functional disruption of the Golgi apparatus protein ARF1 sensitizes MDA-MB-231 breast cancer cells to the antitumor drugs Actinomycin D and Vinblastine through ERK and AKT signaling.

Charlotte Luchsinger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.